SANUWAVE Health, Inc. provided earnings guidance for the First Quarter 2024. For the period, the company expects revenues to be in the range of $5.7 million to $5.9 million, an increase of 51% to 56% over First Quarter 2023 and consistent with the high end of the range of guidance given in the Company?s Fourth Quarter 2023 earnings release from March 22, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0229 USD | +4.09% | +11.71% | +76.15% |
04-10 | Sanuwave Health, Inc. Provides Earnings Guidance for the First Quarter 2024 | CI |
04-01 | SANUWAVE Health, Inc. Appoints Peter Sorensen as CFO | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+76.15% | 26.12M | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- SNWV Stock
- News SANUWAVE Health, Inc.
- Sanuwave Health, Inc. Provides Earnings Guidance for the First Quarter 2024